Global Influenza (Flu) Antiviral Drugs Market Research Report 2026(Status and Outlook)
Antiviral drugs are a class of drugs for the specific treatment of viral infections.The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Influenza (Flu) Antiviral Drugs market size was estimated at USD 1080.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza (Flu) Antiviral Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza (Flu) Antiviral Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza (Flu) Antiviral Drugs market.
Global Influenza (Flu) Antiviral Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Teva Pharmaceutical Industries
Mylan
F. Hoffmann-La Roche
Bristol-Myers-Squibb
Aurobindo Pharma
Cipla
Market Segmentation (by Type)
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Market Segmentation (by Application)
Hospital
Clinic
Household
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Influenza (Flu) Antiviral Drugs Market
Overview of the regional outlook of the Influenza (Flu) Antiviral Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza (Flu) Antiviral Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza (Flu) Antiviral Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Influenza (Flu) Antiviral Drugs market size was estimated at USD 1080.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza (Flu) Antiviral Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza (Flu) Antiviral Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza (Flu) Antiviral Drugs market.
Global Influenza (Flu) Antiviral Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Teva Pharmaceutical Industries
Mylan
F. Hoffmann-La Roche
Bristol-Myers-Squibb
Aurobindo Pharma
Cipla
Market Segmentation (by Type)
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Market Segmentation (by Application)
Hospital
Clinic
Household
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Influenza (Flu) Antiviral Drugs Market
Overview of the regional outlook of the Influenza (Flu) Antiviral Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza (Flu) Antiviral Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza (Flu) Antiviral Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza (Flu) Antiviral Drugs
1.2 Key Market Segments
1.2.1 Influenza (Flu) Antiviral Drugs Segment by Type
1.2.2 Influenza (Flu) Antiviral Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza (Flu) Antiviral Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Influenza (Flu) Antiviral Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza (Flu) Antiviral Drugs Product Life Cycle
3.3 Global Influenza (Flu) Antiviral Drugs Sales by Manufacturers (2020-2025)
3.4 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza (Flu) Antiviral Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza (Flu) Antiviral Drugs Market Competitive Situation and Trends
3.8.1 Influenza (Flu) Antiviral Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza (Flu) Antiviral Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA (FLU) ANTIVIRAL DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Influenza (Flu) Antiviral Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza (Flu) Antiviral Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza (Flu) Antiviral Drugs Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2020-2025)
6.3 Global Influenza (Flu) Antiviral Drugs Market Size by Type (2020-2025)
6.4 Global Influenza (Flu) Antiviral Drugs Price by Type (2020-2025)
7 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza (Flu) Antiviral Drugs Market Sales by Application (2020-2025)
7.3 Global Influenza (Flu) Antiviral Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza (Flu) Antiviral Drugs Sales Growth Rate by Application (2020-2025)
8 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET SALES BY REGION
8.1 Global Influenza (Flu) Antiviral Drugs Sales by Region
8.1.1 Global Influenza (Flu) Antiviral Drugs Sales by Region
8.1.2 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region
8.2 Global Influenza (Flu) Antiviral Drugs Market Size by Region
8.2.1 Global Influenza (Flu) Antiviral Drugs Market Size by Region
8.2.2 Global Influenza (Flu) Antiviral Drugs Market Size by Region
8.3 North America
8.3.1 North America Influenza (Flu) Antiviral Drugs Sales by Country
8.3.2 North America Influenza (Flu) Antiviral Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza (Flu) Antiviral Drugs Sales by Country
8.4.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza (Flu) Antiviral Drugs Sales by Region
8.5.2 Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza (Flu) Antiviral Drugs Sales by Country
8.6.2 South America Influenza (Flu) Antiviral Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza (Flu) Antiviral Drugs Sales by Region
8.7.2 Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza (Flu) Antiviral Drugs by Region(2020-2025)
9.2 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza (Flu) Antiviral Drugs Production
9.4.1 North America Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.4.2 North America Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza (Flu) Antiviral Drugs Production
9.5.1 Europe Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza (Flu) Antiviral Drugs Production (2020-2025)
9.6.1 Japan Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza (Flu) Antiviral Drugs Production (2020-2025)
9.7.1 China Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.7.2 China Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Influenza (Flu) Antiviral Drugs Product Overview
10.1.3 Pfizer Influenza (Flu) Antiviral Drugs Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Influenza (Flu) Antiviral Drugs Product Overview
10.2.3 Roche Influenza (Flu) Antiviral Drugs Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi Influenza (Flu) Antiviral Drugs Product Overview
10.3.3 Sanofi Influenza (Flu) Antiviral Drugs Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Basic Information
10.4.2 Johnson and Johnson Influenza (Flu) Antiviral Drugs Product Overview
10.4.3 Johnson and Johnson Influenza (Flu) Antiviral Drugs Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Merck
10.5.1 Merck Basic Information
10.5.2 Merck Influenza (Flu) Antiviral Drugs Product Overview
10.5.3 Merck Influenza (Flu) Antiviral Drugs Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Influenza (Flu) Antiviral Drugs Product Overview
10.6.3 Novartis Influenza (Flu) Antiviral Drugs Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 AbbVie
10.7.1 AbbVie Basic Information
10.7.2 AbbVie Influenza (Flu) Antiviral Drugs Product Overview
10.7.3 AbbVie Influenza (Flu) Antiviral Drugs Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Basic Information
10.8.2 Gilead Sciences Influenza (Flu) Antiviral Drugs Product Overview
10.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Basic Information
10.9.2 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Overview
10.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Amgen
10.10.1 Amgen Basic Information
10.10.2 Amgen Influenza (Flu) Antiviral Drugs Product Overview
10.10.3 Amgen Influenza (Flu) Antiviral Drugs Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Basic Information
10.11.2 AstraZeneca Influenza (Flu) Antiviral Drugs Product Overview
10.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Product Market Performance
10.11.4 AstraZeneca Business Overview
10.11.5 AstraZeneca Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Basic Information
10.12.2 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Overview
10.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Basic Information
10.13.2 Eli Lilly Influenza (Flu) Antiviral Drugs Product Overview
10.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Teva
10.14.1 Teva Basic Information
10.14.2 Teva Influenza (Flu) Antiviral Drugs Product Overview
10.14.3 Teva Influenza (Flu) Antiviral Drugs Product Market Performance
10.14.4 Teva Business Overview
10.14.5 Teva Recent Developments
10.15 Bayer
10.15.1 Bayer Basic Information
10.15.2 Bayer Influenza (Flu) Antiviral Drugs Product Overview
10.15.3 Bayer Influenza (Flu) Antiviral Drugs Product Market Performance
10.15.4 Bayer Business Overview
10.15.5 Bayer Recent Developments
10.16 Novo Nordisk
10.16.1 Novo Nordisk Basic Information
10.16.2 Novo Nordisk Influenza (Flu) Antiviral Drugs Product Overview
10.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Product Market Performance
10.16.4 Novo Nordisk Business Overview
10.16.5 Novo Nordisk Recent Developments
10.17 Allergan
10.17.1 Allergan Basic Information
10.17.2 Allergan Influenza (Flu) Antiviral Drugs Product Overview
10.17.3 Allergan Influenza (Flu) Antiviral Drugs Product Market Performance
10.17.4 Allergan Business Overview
10.17.5 Allergan Recent Developments
10.18 Takeda
10.18.1 Takeda Basic Information
10.18.2 Takeda Influenza (Flu) Antiviral Drugs Product Overview
10.18.3 Takeda Influenza (Flu) Antiviral Drugs Product Market Performance
10.18.4 Takeda Business Overview
10.18.5 Takeda Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Basic Information
10.19.2 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Overview
10.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Teva Pharmaceutical Industries
10.20.1 Teva Pharmaceutical Industries Basic Information
10.20.2 Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Overview
10.20.3 Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Market Performance
10.20.4 Teva Pharmaceutical Industries Business Overview
10.20.5 Teva Pharmaceutical Industries Recent Developments
10.21 Mylan
10.21.1 Mylan Basic Information
10.21.2 Mylan Influenza (Flu) Antiviral Drugs Product Overview
10.21.3 Mylan Influenza (Flu) Antiviral Drugs Product Market Performance
10.21.4 Mylan Business Overview
10.21.5 Mylan Recent Developments
10.22 F. Hoffmann-La Roche
10.22.1 F. Hoffmann-La Roche Basic Information
10.22.2 F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Overview
10.22.3 F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Market Performance
10.22.4 F. Hoffmann-La Roche Business Overview
10.22.5 F. Hoffmann-La Roche Recent Developments
10.23 Bristol-Myers-Squibb
10.23.1 Bristol-Myers-Squibb Basic Information
10.23.2 Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Overview
10.23.3 Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Market Performance
10.23.4 Bristol-Myers-Squibb Business Overview
10.23.5 Bristol-Myers-Squibb Recent Developments
10.24 Aurobindo Pharma
10.24.1 Aurobindo Pharma Basic Information
10.24.2 Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Overview
10.24.3 Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Market Performance
10.24.4 Aurobindo Pharma Business Overview
10.24.5 Aurobindo Pharma Recent Developments
10.25 Cipla
10.25.1 Cipla Basic Information
10.25.2 Cipla Influenza (Flu) Antiviral Drugs Product Overview
10.25.3 Cipla Influenza (Flu) Antiviral Drugs Product Market Performance
10.25.4 Cipla Business Overview
10.25.5 Cipla Recent Developments
11 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET FORECAST BY REGION
11.1 Global Influenza (Flu) Antiviral Drugs Market Size Forecast
11.2 Global Influenza (Flu) Antiviral Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza (Flu) Antiviral Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Forecast by Region
11.2.4 South America Influenza (Flu) Antiviral Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza (Flu) Antiviral Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Influenza (Flu) Antiviral Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Influenza (Flu) Antiviral Drugs by Type (2026-2035)
12.1.2 Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Influenza (Flu) Antiviral Drugs by Type (2026-2035)
12.2 Global Influenza (Flu) Antiviral Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Influenza (Flu) Antiviral Drugs Sales (K MT) Forecast by Application
12.2.2 Global Influenza (Flu) Antiviral Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza (Flu) Antiviral Drugs
1.2 Key Market Segments
1.2.1 Influenza (Flu) Antiviral Drugs Segment by Type
1.2.2 Influenza (Flu) Antiviral Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza (Flu) Antiviral Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Influenza (Flu) Antiviral Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza (Flu) Antiviral Drugs Product Life Cycle
3.3 Global Influenza (Flu) Antiviral Drugs Sales by Manufacturers (2020-2025)
3.4 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza (Flu) Antiviral Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza (Flu) Antiviral Drugs Market Competitive Situation and Trends
3.8.1 Influenza (Flu) Antiviral Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza (Flu) Antiviral Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA (FLU) ANTIVIRAL DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Influenza (Flu) Antiviral Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza (Flu) Antiviral Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza (Flu) Antiviral Drugs Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2020-2025)
6.3 Global Influenza (Flu) Antiviral Drugs Market Size by Type (2020-2025)
6.4 Global Influenza (Flu) Antiviral Drugs Price by Type (2020-2025)
7 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza (Flu) Antiviral Drugs Market Sales by Application (2020-2025)
7.3 Global Influenza (Flu) Antiviral Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza (Flu) Antiviral Drugs Sales Growth Rate by Application (2020-2025)
8 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET SALES BY REGION
8.1 Global Influenza (Flu) Antiviral Drugs Sales by Region
8.1.1 Global Influenza (Flu) Antiviral Drugs Sales by Region
8.1.2 Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region
8.2 Global Influenza (Flu) Antiviral Drugs Market Size by Region
8.2.1 Global Influenza (Flu) Antiviral Drugs Market Size by Region
8.2.2 Global Influenza (Flu) Antiviral Drugs Market Size by Region
8.3 North America
8.3.1 North America Influenza (Flu) Antiviral Drugs Sales by Country
8.3.2 North America Influenza (Flu) Antiviral Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza (Flu) Antiviral Drugs Sales by Country
8.4.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza (Flu) Antiviral Drugs Sales by Region
8.5.2 Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza (Flu) Antiviral Drugs Sales by Country
8.6.2 South America Influenza (Flu) Antiviral Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza (Flu) Antiviral Drugs Sales by Region
8.7.2 Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza (Flu) Antiviral Drugs by Region(2020-2025)
9.2 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza (Flu) Antiviral Drugs Production
9.4.1 North America Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.4.2 North America Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza (Flu) Antiviral Drugs Production
9.5.1 Europe Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza (Flu) Antiviral Drugs Production (2020-2025)
9.6.1 Japan Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza (Flu) Antiviral Drugs Production (2020-2025)
9.7.1 China Influenza (Flu) Antiviral Drugs Production Growth Rate (2020-2025)
9.7.2 China Influenza (Flu) Antiviral Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Influenza (Flu) Antiviral Drugs Product Overview
10.1.3 Pfizer Influenza (Flu) Antiviral Drugs Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Influenza (Flu) Antiviral Drugs Product Overview
10.2.3 Roche Influenza (Flu) Antiviral Drugs Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi Influenza (Flu) Antiviral Drugs Product Overview
10.3.3 Sanofi Influenza (Flu) Antiviral Drugs Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Basic Information
10.4.2 Johnson and Johnson Influenza (Flu) Antiviral Drugs Product Overview
10.4.3 Johnson and Johnson Influenza (Flu) Antiviral Drugs Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Merck
10.5.1 Merck Basic Information
10.5.2 Merck Influenza (Flu) Antiviral Drugs Product Overview
10.5.3 Merck Influenza (Flu) Antiviral Drugs Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Influenza (Flu) Antiviral Drugs Product Overview
10.6.3 Novartis Influenza (Flu) Antiviral Drugs Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 AbbVie
10.7.1 AbbVie Basic Information
10.7.2 AbbVie Influenza (Flu) Antiviral Drugs Product Overview
10.7.3 AbbVie Influenza (Flu) Antiviral Drugs Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Basic Information
10.8.2 Gilead Sciences Influenza (Flu) Antiviral Drugs Product Overview
10.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Basic Information
10.9.2 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Overview
10.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Amgen
10.10.1 Amgen Basic Information
10.10.2 Amgen Influenza (Flu) Antiviral Drugs Product Overview
10.10.3 Amgen Influenza (Flu) Antiviral Drugs Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Basic Information
10.11.2 AstraZeneca Influenza (Flu) Antiviral Drugs Product Overview
10.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Product Market Performance
10.11.4 AstraZeneca Business Overview
10.11.5 AstraZeneca Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Basic Information
10.12.2 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Overview
10.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Basic Information
10.13.2 Eli Lilly Influenza (Flu) Antiviral Drugs Product Overview
10.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Teva
10.14.1 Teva Basic Information
10.14.2 Teva Influenza (Flu) Antiviral Drugs Product Overview
10.14.3 Teva Influenza (Flu) Antiviral Drugs Product Market Performance
10.14.4 Teva Business Overview
10.14.5 Teva Recent Developments
10.15 Bayer
10.15.1 Bayer Basic Information
10.15.2 Bayer Influenza (Flu) Antiviral Drugs Product Overview
10.15.3 Bayer Influenza (Flu) Antiviral Drugs Product Market Performance
10.15.4 Bayer Business Overview
10.15.5 Bayer Recent Developments
10.16 Novo Nordisk
10.16.1 Novo Nordisk Basic Information
10.16.2 Novo Nordisk Influenza (Flu) Antiviral Drugs Product Overview
10.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Product Market Performance
10.16.4 Novo Nordisk Business Overview
10.16.5 Novo Nordisk Recent Developments
10.17 Allergan
10.17.1 Allergan Basic Information
10.17.2 Allergan Influenza (Flu) Antiviral Drugs Product Overview
10.17.3 Allergan Influenza (Flu) Antiviral Drugs Product Market Performance
10.17.4 Allergan Business Overview
10.17.5 Allergan Recent Developments
10.18 Takeda
10.18.1 Takeda Basic Information
10.18.2 Takeda Influenza (Flu) Antiviral Drugs Product Overview
10.18.3 Takeda Influenza (Flu) Antiviral Drugs Product Market Performance
10.18.4 Takeda Business Overview
10.18.5 Takeda Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Basic Information
10.19.2 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Overview
10.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Teva Pharmaceutical Industries
10.20.1 Teva Pharmaceutical Industries Basic Information
10.20.2 Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Overview
10.20.3 Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Market Performance
10.20.4 Teva Pharmaceutical Industries Business Overview
10.20.5 Teva Pharmaceutical Industries Recent Developments
10.21 Mylan
10.21.1 Mylan Basic Information
10.21.2 Mylan Influenza (Flu) Antiviral Drugs Product Overview
10.21.3 Mylan Influenza (Flu) Antiviral Drugs Product Market Performance
10.21.4 Mylan Business Overview
10.21.5 Mylan Recent Developments
10.22 F. Hoffmann-La Roche
10.22.1 F. Hoffmann-La Roche Basic Information
10.22.2 F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Overview
10.22.3 F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Market Performance
10.22.4 F. Hoffmann-La Roche Business Overview
10.22.5 F. Hoffmann-La Roche Recent Developments
10.23 Bristol-Myers-Squibb
10.23.1 Bristol-Myers-Squibb Basic Information
10.23.2 Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Overview
10.23.3 Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Market Performance
10.23.4 Bristol-Myers-Squibb Business Overview
10.23.5 Bristol-Myers-Squibb Recent Developments
10.24 Aurobindo Pharma
10.24.1 Aurobindo Pharma Basic Information
10.24.2 Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Overview
10.24.3 Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Market Performance
10.24.4 Aurobindo Pharma Business Overview
10.24.5 Aurobindo Pharma Recent Developments
10.25 Cipla
10.25.1 Cipla Basic Information
10.25.2 Cipla Influenza (Flu) Antiviral Drugs Product Overview
10.25.3 Cipla Influenza (Flu) Antiviral Drugs Product Market Performance
10.25.4 Cipla Business Overview
10.25.5 Cipla Recent Developments
11 INFLUENZA (FLU) ANTIVIRAL DRUGS MARKET FORECAST BY REGION
11.1 Global Influenza (Flu) Antiviral Drugs Market Size Forecast
11.2 Global Influenza (Flu) Antiviral Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza (Flu) Antiviral Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Forecast by Region
11.2.4 South America Influenza (Flu) Antiviral Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza (Flu) Antiviral Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Influenza (Flu) Antiviral Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Influenza (Flu) Antiviral Drugs by Type (2026-2035)
12.1.2 Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Influenza (Flu) Antiviral Drugs by Type (2026-2035)
12.2 Global Influenza (Flu) Antiviral Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Influenza (Flu) Antiviral Drugs Sales (K MT) Forecast by Application
12.2.2 Global Influenza (Flu) Antiviral Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza (Flu) Antiviral Drugs Market Size by Type (M USD)
Table 4. Global Influenza (Flu) Antiviral Drugs Market Size by Application
Table 5. Influenza (Flu) Antiviral Drugs Market Size Comparison by Region (M USD)
Table 6. Global Influenza (Flu) Antiviral Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza (Flu) Antiviral Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza (Flu) Antiviral Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2025)
Table 11. Global Market Influenza (Flu) Antiviral Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Influenza (Flu) Antiviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza (Flu) Antiviral Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Influenza (Flu) Antiviral Drugs Sales by Type (K MT)
Table 27. Global Influenza (Flu) Antiviral Drugs Market Size by Type (M USD)
Table 28. Global Influenza (Flu) Antiviral Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Influenza (Flu) Antiviral Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Influenza (Flu) Antiviral Drugs Market Share by Type (2020-2025)
Table 32. Global Influenza (Flu) Antiviral Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Influenza (Flu) Antiviral Drugs Sales (K MT) by Application
Table 34. Global Influenza (Flu) Antiviral Drugs Market Size by Application
Table 35. Global Influenza (Flu) Antiviral Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Influenza (Flu) Antiviral Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Influenza (Flu) Antiviral Drugs Market Share by Application (2020-2025)
Table 39. Global Influenza (Flu) Antiviral Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Influenza (Flu) Antiviral Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025)
Table 44. North America Influenza (Flu) Antiviral Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Influenza (Flu) Antiviral Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Influenza (Flu) Antiviral Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Influenza (Flu) Antiviral Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Influenza (Flu) Antiviral Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Influenza (Flu) Antiviral Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Influenza (Flu) Antiviral Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Influenza (Flu) Antiviral Drugs Product Overview
Table 64. Pfizer Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Influenza (Flu) Antiviral Drugs Product Overview
Table 70. Roche Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi Influenza (Flu) Antiviral Drugs Product Overview
Table 76. Sanofi Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. Johnson and Johnson Basic Information
Table 81. Johnson and Johnson Influenza (Flu) Antiviral Drugs Product Overview
Table 82. Johnson and Johnson Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Johnson and Johnson Business Overview
Table 84. Johnson and Johnson Recent Developments
Table 85. Merck Basic Information
Table 86. Merck Influenza (Flu) Antiviral Drugs Product Overview
Table 87. Merck Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Merck Business Overview
Table 89. Merck Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Influenza (Flu) Antiviral Drugs Product Overview
Table 92. Novartis Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. AbbVie Basic Information
Table 96. AbbVie Influenza (Flu) Antiviral Drugs Product Overview
Table 97. AbbVie Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AbbVie Business Overview
Table 99. AbbVie Recent Developments
Table 100. Gilead Sciences Basic Information
Table 101. Gilead Sciences Influenza (Flu) Antiviral Drugs Product Overview
Table 102. Gilead Sciences Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Business Overview
Table 104. Gilead Sciences Recent Developments
Table 105. GlaxoSmithKline (GSK) Basic Information
Table 106. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Overview
Table 107. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline (GSK) Business Overview
Table 109. GlaxoSmithKline (GSK) Recent Developments
Table 110. Amgen Basic Information
Table 111. Amgen Influenza (Flu) Antiviral Drugs Product Overview
Table 112. Amgen Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Amgen Business Overview
Table 114. Amgen Recent Developments
Table 115. AstraZeneca Basic Information
Table 116. AstraZeneca Influenza (Flu) Antiviral Drugs Product Overview
Table 117. AstraZeneca Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. AstraZeneca Business Overview
Table 119. AstraZeneca Recent Developments
Table 120. Bristol-Myers Squibb Basic Information
Table 121. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Overview
Table 122. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Bristol-Myers Squibb Business Overview
Table 124. Bristol-Myers Squibb Recent Developments
Table 125. Eli Lilly Basic Information
Table 126. Eli Lilly Influenza (Flu) Antiviral Drugs Product Overview
Table 127. Eli Lilly Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Recent Developments
Table 130. Teva Basic Information
Table 131. Teva Influenza (Flu) Antiviral Drugs Product Overview
Table 132. Teva Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Teva Business Overview
Table 134. Teva Recent Developments
Table 135. Bayer Basic Information
Table 136. Bayer Influenza (Flu) Antiviral Drugs Product Overview
Table 137. Bayer Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Bayer Business Overview
Table 139. Bayer Recent Developments
Table 140. Novo Nordisk Basic Information
Table 141. Novo Nordisk Influenza (Flu) Antiviral Drugs Product Overview
Table 142. Novo Nordisk Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Novo Nordisk Business Overview
Table 144. Novo Nordisk Recent Developments
Table 145. Allergan Basic Information
Table 146. Allergan Influenza (Flu) Antiviral Drugs Product Overview
Table 147. Allergan Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Allergan Business Overview
Table 149. Allergan Recent Developments
Table 150. Takeda Basic Information
Table 151. Takeda Influenza (Flu) Antiviral Drugs Product Overview
Table 152. Takeda Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Takeda Business Overview
Table 154. Takeda Recent Developments
Table 155. Boehringer Ingelheim Basic Information
Table 156. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Overview
Table 157. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Boehringer Ingelheim Business Overview
Table 159. Boehringer Ingelheim Recent Developments
Table 160. Teva Pharmaceutical Industries Basic Information
Table 161. Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Overview
Table 162. Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Teva Pharmaceutical Industries Business Overview
Table 164. Teva Pharmaceutical Industries Recent Developments
Table 165. Mylan Basic Information
Table 166. Mylan Influenza (Flu) Antiviral Drugs Product Overview
Table 167. Mylan Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Mylan Business Overview
Table 169. Mylan Recent Developments
Table 170. F. Hoffmann-La Roche Basic Information
Table 171. F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Overview
Table 172. F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. F. Hoffmann-La Roche Business Overview
Table 174. F. Hoffmann-La Roche Recent Developments
Table 175. Bristol-Myers-Squibb Basic Information
Table 176. Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Overview
Table 177. Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Bristol-Myers-Squibb Business Overview
Table 179. Bristol-Myers-Squibb Recent Developments
Table 180. Aurobindo Pharma Basic Information
Table 181. Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Overview
Table 182. Aurobindo Pharma Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Aurobindo Pharma Business Overview
Table 184. Aurobindo Pharma Recent Developments
Table 185. Cipla Basic Information
Table 186. Cipla Influenza (Flu) Antiviral Drugs Product Overview
Table 187. Cipla Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Cipla Business Overview
Table 189. Cipla Recent Developments
Table 190. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 191. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 193. North America Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 195. Europe Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Influenza (Flu) Antiviral Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 197. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 199. South America Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 203. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Influenza (Flu) Antiviral Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 205. Global Influenza (Flu) Antiviral Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 206. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza (Flu) Antiviral Drugs Market Size by Type (M USD)
Table 4. Global Influenza (Flu) Antiviral Drugs Market Size by Application
Table 5. Influenza (Flu) Antiviral Drugs Market Size Comparison by Region (M USD)
Table 6. Global Influenza (Flu) Antiviral Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza (Flu) Antiviral Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza (Flu) Antiviral Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2025)
Table 11. Global Market Influenza (Flu) Antiviral Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Influenza (Flu) Antiviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza (Flu) Antiviral Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Influenza (Flu) Antiviral Drugs Sales by Type (K MT)
Table 27. Global Influenza (Flu) Antiviral Drugs Market Size by Type (M USD)
Table 28. Global Influenza (Flu) Antiviral Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Influenza (Flu) Antiviral Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Influenza (Flu) Antiviral Drugs Market Share by Type (2020-2025)
Table 32. Global Influenza (Flu) Antiviral Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Influenza (Flu) Antiviral Drugs Sales (K MT) by Application
Table 34. Global Influenza (Flu) Antiviral Drugs Market Size by Application
Table 35. Global Influenza (Flu) Antiviral Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Influenza (Flu) Antiviral Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Influenza (Flu) Antiviral Drugs Market Share by Application (2020-2025)
Table 39. Global Influenza (Flu) Antiviral Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Influenza (Flu) Antiviral Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025)
Table 44. North America Influenza (Flu) Antiviral Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Influenza (Flu) Antiviral Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Influenza (Flu) Antiviral Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Influenza (Flu) Antiviral Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Influenza (Flu) Antiviral Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Influenza (Flu) Antiviral Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Influenza (Flu) Antiviral Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Influenza (Flu) Antiviral Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Influenza (Flu) Antiviral Drugs Product Overview
Table 64. Pfizer Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Influenza (Flu) Antiviral Drugs Product Overview
Table 70. Roche Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi Influenza (Flu) Antiviral Drugs Product Overview
Table 76. Sanofi Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. Johnson and Johnson Basic Information
Table 81. Johnson and Johnson Influenza (Flu) Antiviral Drugs Product Overview
Table 82. Johnson and Johnson Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Johnson and Johnson Business Overview
Table 84. Johnson and Johnson Recent Developments
Table 85. Merck Basic Information
Table 86. Merck Influenza (Flu) Antiviral Drugs Product Overview
Table 87. Merck Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Merck Business Overview
Table 89. Merck Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Influenza (Flu) Antiviral Drugs Product Overview
Table 92. Novartis Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. AbbVie Basic Information
Table 96. AbbVie Influenza (Flu) Antiviral Drugs Product Overview
Table 97. AbbVie Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AbbVie Business Overview
Table 99. AbbVie Recent Developments
Table 100. Gilead Sciences Basic Information
Table 101. Gilead Sciences Influenza (Flu) Antiviral Drugs Product Overview
Table 102. Gilead Sciences Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Business Overview
Table 104. Gilead Sciences Recent Developments
Table 105. GlaxoSmithKline (GSK) Basic Information
Table 106. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Overview
Table 107. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline (GSK) Business Overview
Table 109. GlaxoSmithKline (GSK) Recent Developments
Table 110. Amgen Basic Information
Table 111. Amgen Influenza (Flu) Antiviral Drugs Product Overview
Table 112. Amgen Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Amgen Business Overview
Table 114. Amgen Recent Developments
Table 115. AstraZeneca Basic Information
Table 116. AstraZeneca Influenza (Flu) Antiviral Drugs Product Overview
Table 117. AstraZeneca Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. AstraZeneca Business Overview
Table 119. AstraZeneca Recent Developments
Table 120. Bristol-Myers Squibb Basic Information
Table 121. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Overview
Table 122. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Bristol-Myers Squibb Business Overview
Table 124. Bristol-Myers Squibb Recent Developments
Table 125. Eli Lilly Basic Information
Table 126. Eli Lilly Influenza (Flu) Antiviral Drugs Product Overview
Table 127. Eli Lilly Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Recent Developments
Table 130. Teva Basic Information
Table 131. Teva Influenza (Flu) Antiviral Drugs Product Overview
Table 132. Teva Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Teva Business Overview
Table 134. Teva Recent Developments
Table 135. Bayer Basic Information
Table 136. Bayer Influenza (Flu) Antiviral Drugs Product Overview
Table 137. Bayer Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Bayer Business Overview
Table 139. Bayer Recent Developments
Table 140. Novo Nordisk Basic Information
Table 141. Novo Nordisk Influenza (Flu) Antiviral Drugs Product Overview
Table 142. Novo Nordisk Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Novo Nordisk Business Overview
Table 144. Novo Nordisk Recent Developments
Table 145. Allergan Basic Information
Table 146. Allergan Influenza (Flu) Antiviral Drugs Product Overview
Table 147. Allergan Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Allergan Business Overview
Table 149. Allergan Recent Developments
Table 150. Takeda Basic Information
Table 151. Takeda Influenza (Flu) Antiviral Drugs Product Overview
Table 152. Takeda Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Takeda Business Overview
Table 154. Takeda Recent Developments
Table 155. Boehringer Ingelheim Basic Information
Table 156. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Overview
Table 157. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Boehringer Ingelheim Business Overview
Table 159. Boehringer Ingelheim Recent Developments
Table 160. Teva Pharmaceutical Industries Basic Information
Table 161. Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Product Overview
Table 162. Teva Pharmaceutical Industries Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Teva Pharmaceutical Industries Business Overview
Table 164. Teva Pharmaceutical Industries Recent Developments
Table 165. Mylan Basic Information
Table 166. Mylan Influenza (Flu) Antiviral Drugs Product Overview
Table 167. Mylan Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Mylan Business Overview
Table 169. Mylan Recent Developments
Table 170. F. Hoffmann-La Roche Basic Information
Table 171. F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Product Overview
Table 172. F. Hoffmann-La Roche Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. F. Hoffmann-La Roche Business Overview
Table 174. F. Hoffmann-La Roche Recent Developments
Table 175. Bristol-Myers-Squibb Basic Information
Table 176. Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Product Overview
Table 177. Bristol-Myers-Squibb Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Bristol-Myers-Squibb Business Overview
Table 179. Bristol-Myers-Squibb Recent Developments
Table 180. Aurobindo Pharma Basic Information
Table 181. Aurobindo Pharma Influenza (Flu) Antiviral Drugs Product Overview
Table 182. Aurobindo Pharma Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Aurobindo Pharma Business Overview
Table 184. Aurobindo Pharma Recent Developments
Table 185. Cipla Basic Information
Table 186. Cipla Influenza (Flu) Antiviral Drugs Product Overview
Table 187. Cipla Influenza (Flu) Antiviral Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Cipla Business Overview
Table 189. Cipla Recent Developments
Table 190. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 191. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 193. North America Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 195. Europe Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Influenza (Flu) Antiviral Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 197. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 199. South America Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 203. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Influenza (Flu) Antiviral Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 205. Global Influenza (Flu) Antiviral Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 206. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza (Flu) Antiviral Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza (Flu) Antiviral Drugs Market Size (M USD), 2025-2035
Figure 5. Global Influenza (Flu) Antiviral Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Influenza (Flu) Antiviral Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza (Flu) Antiviral Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza (Flu) Antiviral Drugs Product Life Cycle
Figure 13. Influenza (Flu) Antiviral Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Influenza (Flu) Antiviral Drugs Revenue Share by Manufacturers in 2025
Figure 15. Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Influenza (Flu) Antiviral Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza (Flu) Antiviral Drugs Revenue in 2025
Figure 18. Industry Chain Map of Influenza (Flu) Antiviral Drugs
Figure 19. Global Influenza (Flu) Antiviral Drugs Market PEST Analysis
Figure 20. Global Influenza (Flu) Antiviral Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza (Flu) Antiviral Drugs Market Share by Type
Figure 27. Sales Market Share of Influenza (Flu) Antiviral Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Influenza (Flu) Antiviral Drugs by Type in 2025
Figure 29. Market Share of Influenza (Flu) Antiviral Drugs by Type (2020-2025)
Figure 30. Market Share of Influenza (Flu) Antiviral Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza (Flu) Antiviral Drugs Market Share by Application
Figure 33. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application in 2025
Figure 35. Global Influenza (Flu) Antiviral Drugs Market Share by Application (2020-2025)
Figure 36. Global Influenza (Flu) Antiviral Drugs Market Share by Application in 2025
Figure 37. Global Influenza (Flu) Antiviral Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025)
Figure 40. North America Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza (Flu) Antiviral Drugs Sales Market Share by Country in 2024
Figure 43. North America Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza (Flu) Antiviral Drugs Market Size by Country in 2024
Figure 45. U.S. Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza (Flu) Antiviral Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza (Flu) Antiviral Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza (Flu) Antiviral Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza (Flu) Antiviral Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza (Flu) Antiviral Drugs Sales Market Share by Country in 2024
Figure 53. Europe Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza (Flu) Antiviral Drugs Market Size by Country in 2024
Figure 55. Germany Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza (Flu) Antiviral Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza (Flu) Antiviral Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region in 2024
Figure 68. China Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza (Flu) Antiviral Drugs Sales and Growth Rate (K MT)
Figure 79. South America Influenza (Flu) Antiviral Drugs Sales Market Share by Country in 2024
Figure 80. South America Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Influenza (Flu) Antiviral Drugs Market Size by Country in 2024
Figure 82. Brazil Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza (Flu) Antiviral Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Influenza (Flu) Antiviral Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Influenza (Flu) Antiviral Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Influenza (Flu) Antiviral Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Influenza (Flu) Antiviral Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza (Flu) Antiviral Drugs Market Size (M USD), 2025-2035
Figure 5. Global Influenza (Flu) Antiviral Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Influenza (Flu) Antiviral Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza (Flu) Antiviral Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza (Flu) Antiviral Drugs Product Life Cycle
Figure 13. Influenza (Flu) Antiviral Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Influenza (Flu) Antiviral Drugs Revenue Share by Manufacturers in 2025
Figure 15. Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Influenza (Flu) Antiviral Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza (Flu) Antiviral Drugs Revenue in 2025
Figure 18. Industry Chain Map of Influenza (Flu) Antiviral Drugs
Figure 19. Global Influenza (Flu) Antiviral Drugs Market PEST Analysis
Figure 20. Global Influenza (Flu) Antiviral Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza (Flu) Antiviral Drugs Market Share by Type
Figure 27. Sales Market Share of Influenza (Flu) Antiviral Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Influenza (Flu) Antiviral Drugs by Type in 2025
Figure 29. Market Share of Influenza (Flu) Antiviral Drugs by Type (2020-2025)
Figure 30. Market Share of Influenza (Flu) Antiviral Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza (Flu) Antiviral Drugs Market Share by Application
Figure 33. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Application in 2025
Figure 35. Global Influenza (Flu) Antiviral Drugs Market Share by Application (2020-2025)
Figure 36. Global Influenza (Flu) Antiviral Drugs Market Share by Application in 2025
Figure 37. Global Influenza (Flu) Antiviral Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza (Flu) Antiviral Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2020-2025)
Figure 40. North America Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza (Flu) Antiviral Drugs Sales Market Share by Country in 2024
Figure 43. North America Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza (Flu) Antiviral Drugs Market Size by Country in 2024
Figure 45. U.S. Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza (Flu) Antiviral Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza (Flu) Antiviral Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza (Flu) Antiviral Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza (Flu) Antiviral Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza (Flu) Antiviral Drugs Sales Market Share by Country in 2024
Figure 53. Europe Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza (Flu) Antiviral Drugs Market Size by Country in 2024
Figure 55. Germany Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza (Flu) Antiviral Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza (Flu) Antiviral Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region in 2024
Figure 68. China Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza (Flu) Antiviral Drugs Sales and Growth Rate (K MT)
Figure 79. South America Influenza (Flu) Antiviral Drugs Sales Market Share by Country in 2024
Figure 80. South America Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Influenza (Flu) Antiviral Drugs Market Size by Country in 2024
Figure 82. Brazil Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza (Flu) Antiviral Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza (Flu) Antiviral Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza (Flu) Antiviral Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza (Flu) Antiviral Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza (Flu) Antiviral Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Influenza (Flu) Antiviral Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Influenza (Flu) Antiviral Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Influenza (Flu) Antiviral Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Influenza (Flu) Antiviral Drugs Market Share Forecast by Application (2026-2035)
